Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of linezolid in ICU patients with severe MRSA infection
2007-001080-29Phase 4Active
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of linezolid in Staphylococcus aureus infection, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: Population pharmacokinetics of linezolid, Target trough concentration attainment and 3 more. Started May 2007; status: active.
02
Drugs
linezolid
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on 2007-001080-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001080-29.